[go: up one dir, main page]

PL376604A1 - Polimorfy chlorowodorku bicifadyny - Google Patents

Polimorfy chlorowodorku bicifadyny

Info

Publication number
PL376604A1
PL376604A1 PL376604A PL37660403A PL376604A1 PL 376604 A1 PL376604 A1 PL 376604A1 PL 376604 A PL376604 A PL 376604A PL 37660403 A PL37660403 A PL 37660403A PL 376604 A1 PL376604 A1 PL 376604A1
Authority
PL
Poland
Prior art keywords
polymorphs
bicifadine hydrochloride
bicifadine
hydrochloride
Prior art date
Application number
PL376604A
Other languages
English (en)
Inventor
Brenton William Russell
Rex Alwyn Shipplett
Kevin John Halloran
Original Assignee
Dov Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dov Pharmaceuticals, Inc. filed Critical Dov Pharmaceuticals, Inc.
Publication of PL376604A1 publication Critical patent/PL376604A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL376604A 2002-11-08 2003-11-05 Polimorfy chlorowodorku bicifadyny PL376604A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42498202P 2002-11-08 2002-11-08
US10/702,397 US7094799B2 (en) 2002-11-08 2003-11-05 Polymorphs of bicifadine hydrochloride

Publications (1)

Publication Number Publication Date
PL376604A1 true PL376604A1 (pl) 2006-01-09

Family

ID=32314565

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376604A PL376604A1 (pl) 2002-11-08 2003-11-05 Polimorfy chlorowodorku bicifadyny

Country Status (12)

Country Link
US (2) US7094799B2 (pl)
EP (1) EP1562900A4 (pl)
JP (1) JP2006519162A (pl)
KR (1) KR20050075382A (pl)
AU (1) AU2003286889A1 (pl)
BR (1) BR0315433A (pl)
CA (1) CA2504732A1 (pl)
MX (1) MXPA05004873A (pl)
NO (1) NO20052676L (pl)
PL (1) PL376604A1 (pl)
RU (1) RU2005117630A (pl)
WO (1) WO2004043920A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
JP2006519162A (ja) * 2002-11-08 2006-08-24 ディオーブイ ファーマシューティカル，インク． ビシファジン塩酸塩の多形
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
EP1879578A4 (en) * 2005-03-21 2009-05-13 Dov Pharmaceutical Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
US20070082939A1 (en) * 2005-07-26 2007-04-12 Lippa Arnold S Methods and compositions for the treatment of neuropathies and related disorders
CA2659215C (en) * 2005-07-27 2018-07-10 Dov Pharmaceutical, Inc. Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US20080269348A1 (en) * 2006-11-07 2008-10-30 Phil Skolnick Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US20090069374A1 (en) * 2007-06-06 2009-03-12 Phil Skolnick Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
WO2009023820A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Improving the tolerability of a serotonin antagonist and a nsri, a snri or a rima by using them in combination
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
KR20140062472A (ko) 2011-09-15 2014-05-23 데메알엑스, 인크. 노르이보가인 염 무용매화물
SI3597189T1 (sl) 2015-06-17 2022-08-31 Otsuka America Pharmaceutical, Inc. Kristalinične spojine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231935A (en) 1975-07-31 1980-11-04 American Cyanamid Company 1-Phenyl-3-azabicyclo[3.1.0]hexanes
US4196120A (en) 1975-07-31 1980-04-01 American Cyanamid Company Azabicyclohexanes, method of use and preparation of the same
GB1532682A (en) 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4435419A (en) * 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
US6204284B1 (en) * 1991-12-20 2001-03-20 American Cyanamid Company Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
JP2006519162A (ja) * 2002-11-08 2006-08-24 ディオーブイ ファーマシューティカル，インク． ビシファジン塩酸塩の多形

Also Published As

Publication number Publication date
WO2004043920A8 (en) 2005-07-21
KR20050075382A (ko) 2005-07-20
US7094799B2 (en) 2006-08-22
AU2003286889A1 (en) 2004-06-03
JP2006519162A (ja) 2006-08-24
EP1562900A1 (en) 2005-08-17
NO20052676D0 (no) 2005-06-03
RU2005117630A (ru) 2006-01-20
US20040102638A1 (en) 2004-05-27
MXPA05004873A (es) 2005-12-05
CA2504732A1 (en) 2004-05-27
US20070149599A1 (en) 2007-06-28
NO20052676L (no) 2005-08-03
EP1562900A4 (en) 2006-07-12
WO2004043920A1 (en) 2004-05-27
BR0315433A (pt) 2005-08-30

Similar Documents

Publication Publication Date Title
EG23458A (en) Set of elements for assemlying structures
PL377087A1 (pl) Związki heterocykliczne
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
PL376604A1 (pl) Polimorfy chlorowodorku bicifadyny
HU0200438D0 (en) Novel clopidogrel hydrochloride polymorphs
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
EP1577280A4 (en) DEUTERATION PROCESS
EP1476425A4 (en) Heterocyclic Aryl Sulphonamidocyclic Compounds
HRP20030900A2 (en) Polymorphs of fexofenadine hydrochloride
IL175654A0 (en) Cycloalkyl derivatives of 3-hydroxy -4-pyridinones
EP1488046A4 (en) CONSTRUCTION METHODS
AU2003216848A8 (en) Deracemisation of amines
AU2003262141A8 (en) Preperation of desloratatine
PL373802A1 (pl) Polimorficzne formy pochodnych fenylooksazolidynonu
PL375437A1 (pl) Synteza gatifloksacyny
AU2003300814A8 (en) Polymorphic forms of ziprasidone and its hydrochloride
AU2003217354A8 (en) Synthesis of sulfamidates
PL356853A1 (pl) Zastosowanie bakteriofagów
GB2387171B (en) Synthesis of enamines
AU153628S (en) Set of frames
AU151591S (en) Set of frames
SI1537210T1 (sl) Lazna oligonukleotidna inhibicija ekspresije CD40
AU154624S (en) A set of frames
AU154623S (en) A set of frames

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)